Experts who define diseases often tied to drug companies

A new study published in the influential open access medical journal PLOS Medicine, has found that many of the experts who define diseases – and often widen those definitions – also work as paid consultants and speakers for drug companies which stand to benefit from their decisions. You can see the free full text of the study here